Related references
Note: Only part of the references are listed.A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 Omicron variant
Collin Jugler et al.
PLANT BIOTECHNOLOGY JOURNAL (2023)
Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus
Haiyan Sun et al.
VACCINES (2023)
In vitro and in vivo models for monkeypox
Rafael Borges Rosa et al.
ISCIENCE (2023)
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
MacGregor Cox et al.
NATURE REVIEWS MICROBIOLOGY (2023)
A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics
Haiyan Sun et al.
VIRUSES-BASEL (2023)
Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
Ming Yang et al.
VACCINES (2023)
Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus
Ye Sang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Development of plant-made monoclonal antibodies viral infections
Qiang Chen
CURRENT OPINION IN VIROLOGY (2022)
Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters
Yan Xiang et al.
EMERGING MICROBES & INFECTIONS (2022)
Vaccination for Monkeypox Virus Infection in Humans: A Review of Key Considerations
Kay Choong See
VACCINES (2022)
SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
Collin Jugler et al.
VACCINES (2021)
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Co-expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants
Emmanuel Margolin et al.
PLANT BIOTECHNOLOGY JOURNAL (2020)
Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts via Aqueous Two-Phase Separation
Collin Jugler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
N-Glycosylation of IgG and IgG-Like Recombinant Therapeutic Proteins: Why Is It Important and How Can We Control It?
Natalia I. Majewska et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 11 (2020)
Production of Biopharmaceuticals in Nicotiana benthamiana-Axillary Stem Growth as a Key Determinant of Total Protein Yield
Marie-Claire Goulet et al.
FRONTIERS IN PLANT SCIENCE (2019)
The less-is-more in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity
Natasha A. Pereira et al.
MABS (2018)
The Rise and Rise of Nicotiana benthamiana: A Plant for All Reasons
Julia Bally et al.
ANNUAL REVIEW OF PHYTOPATHOLOGY, VOL 56 (2018)
N-glycan engineering of a plant-produced anti-CD20-hIL-2 immunocytokine significantly enhances its effector functions
Carla Marusic et al.
BIOTECHNOLOGY AND BIOENGINEERING (2018)
Beyond binding: antibody effector functions in infectious diseases
Lenette L. Lu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
Michaela Seeling et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems - The taliglucerase alfa story
Bonita Rup et al.
PLOS ONE (2017)
Techno-economic analysis of a transient plant-based platform for monoclonal antibody production
Somen Nandi et al.
MABS (2016)
Plant specific N-glycans do not have proven adverse effects in humans
Yoseph Shaaltiel et al.
NATURE BIOTECHNOLOGY (2016)
Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms
Qiang Chen
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Purification of monoclonal antibody against Ebola GP1 protein expressed in Nicotiana benthamiana
Andrew Fulton et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo
Jeffrey R. Kugelman et al.
EMERGING INFECTIOUS DISEASES (2014)
Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors
Matthew E. Cohen et al.
PLOS ONE (2011)
Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease
Joseph W. Golden et al.
VIROLOGY JOURNAL (2011)
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo
Anne W. Rimoin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine
Mohammed Rafii-El-Idrissi Benhnia et al.
JOURNAL OF VIROLOGY (2008)
Vaccinia virus L1 protein is required for cell entry and membrane fusion
Himani Bisht et al.
JOURNAL OF VIROLOGY (2008)
Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein
Hua-Poo Su et al.
VIROLOGY (2007)
Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge
S Lustig et al.
JOURNAL OF VIROLOGY (2005)
Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus
Y Edghill-Smith et al.
NATURE MEDICINE (2005)
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses
IM Belyakov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates
JW Hooper et al.
VIROLOGY (2003)